- Persephone to utilize the Bacteroides technology for the rapid generation of therapeutics from its planned and ongoing biomarker studies, including the ARGONAUT study
- Ginkgo retains the rights.
Probiota Americas is just over two weeks away. With key scientific and business insights into microbiome modulation to support women’s health, LBPs, and quorum sensing, don’t wait to register!
Study of the gut health of babies at San Diego’s Persephone Biosciences hopes to reveal what builds the microbiome and whether new medications can replace what’s missing.
Persephone Biosciences, a preclinical biotech focused on microbiome-based medicines, raised $15 million in seed funding on Tuesday. The company will use the money to advance its trial for oncology therapeutics, as well as to continue developing its preventive medicine for infants.